374
Views
11
CrossRef citations to date
0
Altmetric
Review Article

Management of granulomatous cerebral aspergillosis in immunocompetent adult patients: a review

, , &
Pages 280-285 | Received 09 Aug 2014, Accepted 03 Jan 2016, Published online: 06 Feb 2016

References

  • Challa S, Uppin SG, Purohit AK. Isolated cerebral Aspergillus granuloma with no obvious source of infection. Neurol India 2007;55:289–91.
  • Siddiqui AA, Shah AA, Bashir SH. Craniocerebral aspergillosis of sinonasal origin in immunocompetent patients: clinical spectrum and outcome in 25 cases. Neurosurgery 2004;55:602–11.
  • Okugawa S, Ota Y, Tatsuno K, et al. A case of invasive central nervous system aspergillosis treated with micafungin with monitoring of micafungin concentrations in the cerebrospinal fluid. Scand J Infect Dis 2007;39:344–6.
  • Sundaram C, Umabala P, Laxmi V, et al. Pathology of fungal infections of the central nervous system: 17 years' experience from Southern India. Histopathology 2006;49:396–405.
  • Shankar SK, Mahadevan A, Sundaram C, et al. Pathobiology of fungal infections of the central nervous system with special reference to the Indian scenario. Neurol India 2007;55:198–215.
  • Nadkarni T, Goel A. Aspergilloma of the brain: an overview. J Postgrad Med 2005;51:S37–41.
  • Scully EP, Baden LR, Katz JT. Fungal brain infections. Curr Opin Neurol 2008;21:347–52.
  • Shamim MS, Siddiqui AA, Enam SA, et al. Craniocerebral aspergillosis in immunocompetent hosts: surgical perspective. Neurol India 2007;55:274–81.
  • Denning DW. Therapeutic outcome in invasive aspergillosis. Clin Infect Dis 1996;23:608–15.
  • Naim Ur R, Jamjoom A, al-Hedaithy SS, et al. Cranial and intracranial aspergillosis of sino-nasal origin. Report of nine cases. Acta Neurochir (Wien) 1996;138:944–50.
  • Bokhari R, Baeesa S, Al-Maghrabi J, Madani T. Isolated Cerebral Aspergillosis in Immunocompetent Patients. World Neurosurg 2014;82:e325–3.
  • Spapen H, Spapen J, Taccone FS, et al. Cerebral aspergillosis in adult critically ill patients: a descriptive report of 10 patients from the AspICU cohort. Int J Antimicrob Agents 2014;43:165–9.
  • Ducolin C, Zuiani C, Sbuelz M, et al. Invasive cerebral aspergillosis in an immunocompetent patient. A case report. Neuroradiol J 2008;21:173–7.
  • Brun S, Fekkar A, Busse A, et al. Aspergillus flavus brain abscesses associated with hepatic amebiasis in a non-neutropenic man in Senegal. Am J Trop Med Hyg 2009;81:583–6.
  • Walsh TJ, Anaissie EJ, Denning DW, et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008;46:327–60.
  • Kowacs PA, Monteiro de Almeida S, Pinheiro RL, et al. Central nervous system Aspergillus fumigatus infection after near drowning. J Clin Pathol 2004;57:202–4.
  • Cocchi S, Codeluppi M, Guaraldi G, et al. Invasive pulmonary and cerebral aspergillosis in a patient with Weil's disease. Scand J Infect Dis 2005;37:396–8.
  • Haran RP, Chandy MJ. Intracranial aspergillus granuloma. Br J Neurosurg 1993;7:383–8.
  • Darras-Joly C, Veber B, Bedos JP, et al. Nosocomial cerebral aspergillosis: a report of 3 cases. Scand J Infect Dis 1996;28:317–19.
  • Golin V, Sprovieri SR, Cancado JE, et al. Aspergillosis of the central nervous system. Sao Paulo Med J 1996;114:1274–7.
  • Letscher V, Herbrecht R, Gaudias J, et al. Post-traumatic intracranial epidural Aspergillus fumigatus abscess. J Med Vet Mycol 1997;35:279–82.
  • Elgamal EA, Murshid WR. Intracavitary administration of amphotericin B in the treatment of cerebral aspergillosis in a non immune-compromised patient: case report and review of the literature. Br J Neurosurg 2000;14:137–41.
  • Nadkarni TD, Desai KI, Muzumdar D, et al. Ischaemic complications after surgical resection of intracranial aspergilloma. J Clin Neurosci 2003;10:500–2.
  • Palanisamy A, Chao SD, Fouts M, Kerr D. Central nervous system aspergillosis in an immunocompetent patient: cure in a hospice setting with very high-dose itraconazole. Am J Hosp Palliat Care 2005;22:139–44.
  • Marinovic T, Skrlin J, Vilendecic M, et al. Multiple Aspergillus brain abscesses in immuno-competent patient with severe cranio-facial trauma. Acta Neurochir (Wien) 2007;149:629–32.
  • Nabika S, Kiya K, Satoh H, et al. Local administration of amphotericin B against aspergilloma in the prepontine cistern-case report. Neurol Med Chir (Tokyo) 2007;47:89–92.
  • Pradhan S, Yadav R. Invasive aspergillosis of the brain: improvement with lyposomal amphoterecin B and itraconazole. Neurol India 2007;55:309–10.
  • Traboulsi RS, Kattar MM, Dbouni O, et al. Fatal brain infection caused by Aspergillus glaucus in an immunocompetent patient identified by sequencing of the ribosomal 18S-28S internal transcribed spacer. Eur J Clin Microbiol Infect Dis 2007;26:747–50.
  • Narayan SK, Kumar K, Swaminathan RP, et al. Isolated cerebral aspergilloma in a young immunocompetent patient. Pract Neurol 2009;9:166–8.
  • Chen S, Pu JL, Yu J, Zhang JM. Multiple Aspergillus cerebellar abscesses in a middle-aged female: case report and literature review. Int J Med Sci 2011;8:635–9.
  • Iyeyasu JN, Reis F, Altemani AM, Carvalho KM. Intracranial and orbital aspergillosis in immunocompetent patient. Arq Neuropsiquiatr 2011;69:141.
  • Kose S, Cavdar G, Senger SS, Akkoclu G. Central nervous system aspergillosis in an immunocompetent patient. J Infect Dev Ctries 2011;5:313–15.
  • Lee JC, Lim DJ, Ha SK, et al. Fatal case of cerebral aspergillosis: a case report and literature review. J Korean Neurosurg Soc 2012;52:420–2.
  • Pelaez T, Gijon P, Bunsow E, et al. Resistance to voriconazole due to a G448S substitution in Aspergillus fumigatus in a patient with cerebral aspergillosis. J Clin Microbiol 2012;50:2531–4.
  • Kruetzelmann A, Sobottka I, Fiehler J, et al. Relapsing cerebral aspergilloma associated with pregnancy. Clin Neurol Neurosurg 2013;115:1154–6.
  • Renard JE, Onnient Y, Proust F, et al. Neuroaspergillosis and brain tuberculosis in an immunocompetent patient with good outcome. J Neurol Neurosurg Psychiatry 1998;64:411–12.
  • Safdar A, Dommers MP, Jr., Talwani R, Thompson CR. Intracranial perineural extension of invasive mycosis: a novel mechanism of disease propagation by Aspergillus fumigatus. Clin Infect Dis 2002;35:e50–3.
  • de Lastours V, Lefort A, Zappa M, et al. Two cases of cerebral aspergillosis successfully treated with voriconazole. Eur J Clin Microbiol Infect Dis 2003;22:297–9.
  • Pagliano P, Attanasio V, Fusco U, et al. Pulmonary aspergillosis with possible cerebral involvement in a previously healthy pregnant woman. J Chemother 2004;16:604–7.
  • Wasay M, Patel J, Azam I Jr., et al., Preoperative antifungal therapy may improve survival in patients with Aspergillus brain abscess. Clin Neurol Neurosurg 2009;111:565–7.
  • Das SK, Bhattacharya S, Mitra K, et al. Central nervous system fungal infection-a report of three cases. J Indian Med Assoc 2004;102:634–6.
  • Kulkarni V, Rajshekhar V, Mathews MS. An isolated non-dural-based cerebellar aspergilloma in an immunocompetent patient. Neurol India 2007;55:310–11.
  • Yan B, Wu X, Zhou D. Invasive intracranial aspergillosis in an immunocompetent patient after dental extraction. Scand J Infect Dis 2011;43:156–8.
  • Xiao A, Jiang S, Liu Y, et al. Invasive intracranial aspergillosis spread by the pterygopalatine fossa in an immunocompetent patient. Braz J Infect Dis 2012;16:192–5.
  • Ellenbogen JR, Waqar M, Denning DW, et al. Posaconazole responsive cerebral aspergillosis in an immunocompetent adult. J Clin Neurosci 2014;21:1825–7.
  • Mikolich DJ, Kinsella LJ, Skowron G, et al. Aspergillus meningitis in an immunocompetent adult successfully treated with itraconazole. Clin Infect Dis 1996;23:1318–19.
  • Bunc G, Vorsic M. Long-term survival following treatment of multiple supra- and infratentorial aspergillus brain abscesses. Wien Klin Wochenschr 2001;113 Suppl 3:69–74.
  • Alapatt JP, Kutty RK, Gopi PP, Challissery J. Middle and posterior fossa aspergilloma. Surg Neurol 2006;66:75–8.
  • Yanai Y, Wakao T, Fukamachi A, Kunimine H. Intracranial granuloma caused by Aspergillus fumigatus. Surg Neurol 1985;23:597–604.
  • Morioka T, Tashima T, Nagata S, et al. Cerebral aspergillosis after burr-hole surgery for chronic subdural hematoma: case report. Neurosurgery 1990;26:332–5.
  • Scamoni C, Dario A, Pozzi M, Dorizzi A. Drainage of Aspergillus “urvival. Case report.” brain abscess with long-term survival. Case report. J Neurosurg Sci 1990;34:155–8.
  • Kawakami N, Nishizaki T, Sugiyama S, Ito H. Aspergillus brain abscess in a patient with normal immunity-case report. Neurol Med Chir (Tokyo) 1994;34:237–40.
  • Pongbhaesaj P, Dejthevaporn C, Tunlayadechanont S, et al. Aspergillosis of the central nervous system: a catastrophic opportunistic infection. Southeast Asian J Trop Med Public Health 2004;35:119–25.
  • Srinivasan US. Intracranial aspergilloma in immunocompetent patients successfully treated with radical surgical intervention and antifungal therapy: case series. Ann Acad Med Singapore 2008;37:783–7.
  • Chen DC, Wu TH, Chen SC, et al. Isolated intraventricular aspergillosis in a schizophrenic patient. J Craniofac Surg 2010;21:1291–4.
  • Aslam E, Imran M, Muhammad T, Faridi N. Rhinocerebral aspergillosis cripple: high oral doses of Itraconazole was the solution. J Pak Med Assoc 2006;56:415–16.
  • Goel A, Nadkarni T, Desai AP. Aspergilloma in the paracavernous region-two case reports. Neurol Med Chir (Tokyo) 1996;36:733–6.
  • Jayashree P, Puranik R, Kulkarni MH. Cerebral aspergilloma presenting as atypical meningioma in an immunologically competent patient: a case report. Indian J Pathol Microbiol 2007;50:367–9.
  • Siddiqui K, Douglas M, Carey M, Benamer H. A case of invasive aspergillosis in a patient with no identifiable immunodeficiencies. Libyan J Med 2008;3:49–51.
  • Schwartz S, Reisman A, Troke PF. The efficacy of voriconazole in the treatment of 192 fungal central nervous system infections: a retrospective analysis. Infection 2011;39:201–10.
  • Moen MD, Lyseng-Williamson KA, Scott LJ. Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections. Drugs 2009;69:361–92.
  • Clemons KV, Espiritu M, Parmar R, Stevens DA. Comparative efficacies of conventional amphotericin b, liposomal amphotericin B (AmBisome), caspofungin, micafungin, and voriconazole alone and in combination against experimental murine central nervous system aspergillosis. Antimicrob Agents Chemother 2005;49:4867–75.
  • Krishnan-Natesan S, Chandrasekar PH. Current and future therapeutic options in the management of invasive aspergillosis. Drugs 2008;68:265–82.
  • Muijsers RB, Goa KL, Scott LJ. Voriconazole: in the treatment of invasive aspergillosis. Drugs 2002;62:2655–6.
  • Keating GM. Posaconazole. Drugs 2005;65:1553–67.
  • Frampton JE, Perry CM. Ibandronate: a review of its use in the management of postmenopausal osteoporosis. Drugs 2008;68:2683–707.
  • Pitisuttithum P, Negroni R, Graybill JR, et al. Activity of posaconazole in the treatment of central nervous system fungal infections. J Antimicrob Chemother 2005;56:745–55.
  • Atherton G. Antifungal interactions 2014. Available from: http://www.aspergillus.org.uk/nac/interactions/patientchoosegeneric.php [last accessed 12 Jan 2016].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.